Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 399,757 | 271,772 | 227,827 | 148,380 | 187,986 |
| Receivables | 37,258 | 10,954 | 9,282 | 15,583 | 8,260 |
| Inventories | 6,249 | N/A | N/A | N/A | N/A |
| Other current assets | 2,735 | 3,365 | 3,388 | 2,063 | 1,720 |
| TOTAL | $453,572 | $289,708 | $242,996 | $170,063 | $202,504 |
| Non-Current Assets | |||||
| PPE Net | 1,105 | 24 | 73 | 80 | 107 |
| Intangibles | 545 | 545 | 545 | 545 | 545 |
| Other Non-Current Assets | 19,020 | 17,847 | 15,854 | 15,899 | 1,050 |
| TOTAL | $20,670 | $18,416 | $16,472 | $16,524 | $1,702 |
| Total Assets | $474,242 | $308,124 | $259,468 | $186,587 | $204,206 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,366 | 3,492 | 2,910 | 10,044 | 178 |
| Accrued Expenses | 16,757 | 3,585 | 13,752 | 22,256 | 10,863 |
| Other current liabilities | 3,549 | 435 | 1,409 | 327 | 2,364 |
| TOTAL | $42,681 | $8,692 | $19,029 | $33,422 | $14,203 |
| Non-Current Liabilities | |||||
| Long Term Debt | 120,341 | 48,374 | 9,768 | 4,874 | 4,635 |
| Other Non-Current Liabilities | 106,661 | 1,775 | 0 | 0 | 0 |
| TOTAL | $227,002 | $50,149 | $9,973 | $5,160 | $5,149 |
| Total Liabilities | $269,683 | $58,841 | $29,002 | $38,582 | $19,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,979 | 80,816 | 78,988 | 60,368 | N/A |
| Common Shares | 45,021 | 42,771 | 40,526 | 31,855 | 31,794 |
| Retained earnings | -562,401 | -388,433 | -333,097 | -263,716 | -207,050 |
| Other shareholders' equity | -4,260 | -4,118 | -4,150 | -4,204 | -4,301 |
| TOTAL | $204,559 | $249,283 | $230,466 | $148,005 | $184,854 |
| Total Liabilities And Equity | $474,242 | $308,124 | $259,468 | $186,587 | $204,206 |